KALA BIO, Inc. (KALA): Insider Trading, Congress Trades & Research | Tormere

KALA

$0.17+3.47%visit website

KALA BIO, Inc.

Market Cap

$10M

Finnhub, as of 2026-09-20

Sector

Health Care

Industry

Biotechnology

Beta (raw)

-2.34

60mo monthly vs SPY

P/E (TTM)

—

Price / TTM diluted EPS

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

—

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	6,127		61	59
Total operating expenses	7,239	10,225	1,802	1,721	20,987
Operating income	(7,239)	(10,225)	(1,802)	(1,721)	(20,987)
Interest expense	963	141
Net income	(7,564)	686	(1,621)	(1,581)	(10,080)
EPS (basic) ($)	(1.07)		(0.14)	(21.32)	—
EPS (diluted) ($)	(1.07)		(0.14)	(21.32)	—
Weighted avg. shares (basic)	7,042		11,874	74
Weighted avg. shares (diluted)	7,042		11,874	74

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 19, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 38 more quarters, back to Mar 2016, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

Lazar David E. · 2026-07-02

No Form 4 transactions on record.

Recent News

More than 14 million votes back reverse split authority for KALA BIO (KALA).

Stock Titan · 2026-11-03

Kala Pharmaceuticals Stock Price Forecast. Should You Buy KALA?

StockInvest.us · 2026-10-30

KALA BIO, Inc. Estimates – NASDAQ:KALA

TradingView · 2026-10-24

12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga · 2026-10-23

Why FingerMotion Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Kala Bio

Benzinga · 2026-09-30

A telehealth platform has generated over $48 million in sales since 2023. KALA Bio may buy it.

Stock Titan · 2026-09-29

KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team

Yahoo Finance · 2026-09-17

Kala Bio Signs Exclusive U.S. Distribution Agreement for Virotek Ophthalmology Genetic Tests

Yahoo Finance · 2026-09-03

Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Yahoo Finance · 2026-09-03

On Thursday, there are stocks with unusual volume. Let's take a look.

ChartMill · 2026-09-03

Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Yahoo Finance · 2026-09-01

Kala Bio Targets Near-Term Revenue With Virotek Ophthalmology Genetic Testing Partnership

Yahoo Finance · 2026-09-01

KALA BIO Faces Nasdaq Listing Compliance Uncertainty

The Globe and Mail · 2026-08-29

KALA BIO Announces Reverse Stock Split

Yahoo Finance · 2026-05-07

Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine

Yahoo Finance · 2026-04-21

Informational purposes only, not investment advice.